Hfo 3
Hfo 3
til then, healthy areas of the lung, reproducing the                   greater in the ventilator circuit and in the tracheal
anatomy-pathological injuries of ARDS, worsening                       proximal portion, progressively decreasing along the
hypoxemia and patients’ evolution.(5,6)                                airway, resulting in low pressure amplitude in the al-
    Thus VILI may be defined as a simulation of acute                  veoli.
pulmonary injury taking place in patients submitted                       Literature review and selection of more relevant
to MV. Repetitive overdistension of the lungs and                      publications on high frequency ventilation using as
subsequent development of atelectasia contribute to                    database MedLine and SciElo published in the last 15
pulmonary injury, which is caused by using the ven-                    years was carried out. The following key words wee
tilator standard for oxygenation and ventilation sup-                  used: high frequency oscillatory ventilation, mechani-
port. A cyclic change in pulmonary volume may be a                     cal ventilation, acute respiratory distress syndrome
significant cause of MVIPI, suggesting that a ventila-                 and new-born.
tion strategy avoiding major pulmonary volume varia-
tions might be beneficial.(7,8)                                          CLINICAL APLICATIONS OF HFOV IN PE-
    The concept of protective mechanical ventilation                   DIATRICS
emerged from the understanding of VILI. It may be
defined as a ventilation that minimizes tidal volume,                      Acute pulmonary injury and acute respiratory
maintains a low peak inspiratory pressure, offers a                    distress syndrome
sufficient positive end expiratory pressure (PEEP) to                      The combination of low volume and pressure vari-
maintain alveolar opening, avoiding alveolar collapse                  ation and maintenance of constant mean airway pres-
and cyclic opening and closing of the alveolar units,                  sure (MAP) make use of HFOV attractive for ARDS.
uses non-toxic concentrations of oxygen and permits                    Maintenance of pulmonary volume avoids pulmonary
hypercapnia.(5,7)                                                      overdistension as well as occurrence of atelectasia in
    Although CMV is effective for most children, there                 patients with ARDS and the flow standard may im-
is a significant number of patients with severe respira-               prove in relation to ventilation-perfusion. (11,12)
tory failure for whom CMV may not assure oxygen-                           Successful treatment of ARDS requires a strategy
ation and ventilation. In such cases, when protective                  to keep the lungs open, the open lung approach. Re-
mechanical ventilation is mandatory, high frequency                    cruitment of collapsed alveoli reduces intrapulmo-
oscillatory ventilation (HFOV) becomes an attractive                   nary shunt, reducing the fraction of inspired oxygen
alternative.(9)                                                        (FiO2) to less toxic concentrations. It was shown that
    HFOV is a ventilation mode that uses a lower tidal                 children with ARDS have a significant improvement
volume than the anatomic dead space volume (1–3                        in oxygenation, lower incidence of barotraumas and
mL/Kg) with a frequency well above the physiologi-                     better results with use of HFOV, (9) without influenc-
cal one (5–10 Hertz), that is to say, 300-600 cycles/                  ing mortality. In adults with ARDS an immediate and
minute). This ventilation mode has been successfully                   sustained improvement was reported in relation to
used to treat patients with severe respiratory failure                 partial oxygen pressure (PaO2)/FiO2 when patients
when CMV fails, Furthermore, reports state that                        were submitted to HFOV combined with alveolar
when HFOV is used earlier, together with a protective                  recruitment maneuvers.(13) An additional benefit was
strategy, a decrease of the acute or chronic pulmonary                 shown to be reduction of inflammatory mediators in
injury occurs in patients with ARDS.(5,10,11)                          samples of bronchoalveolar lavage of patients with
    The 3100A by SensorMedics® ventilator is approved                  HFOV when compared to CMV.(1,6) Further, in these
by Food and Drug Administration (FDA) for use in                       studies with adults, no statistical difference was ob-
children up to 35 kg. This is a device for mechanical                  served in mortality when comparing HFOV to CMV.
pulmonary ventilation with a continuous flow of gas                    It is noteworthy that these studies call attention to
capable of eliminating CO2 and keeping airway pres-                    early introduction of HFOV in ARDS when benefits
sure constant. The ventilator has an electromagnetic                   could be more easily demonstrated.
piston that generates high frequency oscillation on                        To summarize, in cases of ARDS, the HFOV is an
the air flow, establishing pressure oscillation ampli-                 important therapeutic tool and although, decrease of
tude. Contrary to the CMV, in HFOV tidal volume is                     mortality with use of this ventilation mode has not
inversely related to frequency and inspiration as well                 been proven, studies focusing on its early utilization
as expiration is active. The amplitude of pressure is                  must be implemented.
    Air leak syndrome                                        tilator induced injuries (4) were observed. This included
    Pneumothorax, mediastinal emphysema and pul-             bronchopulmonary displasia (BPD) and occurrence of
monary interstitial air are observed in acute pulmo-         air leak (pneumothorax, pneumomediastinum, etc.).
nary injury as a result of base disease as well as venti-    To reduce occurrence of BPD various modifications
lation therapy. HFOV has been successfully used for          in the ventilation strategies were introduced, and the
these patients(14,15) emphasizing that the strategy must     less aggressive MV strategy was implemented. In this
encompass low MAP and use of pressure amplitude at           aspect, use of HFOV in neonatology as previously de-
lower values, needed to keep adequate alveolar venti-        scribed for older children emerged as an important
lation, resolving the air leak. In such cases a high FiO 2   technique for pulmonary protection.
must be permitted for short periods, accepting arte-             Since its introduction in neonatology in 1981,
rial oxygen saturation (SaO 2) > 85% as long as oxygen       including 8 new-born with ARDS, various studies
release is adequate, lactic acidosis does not occur and      have been carried out to evaluate efficacy and safety
the patient is hemodynamically stable.(1,12) Decrease of     of HFOV in relation to CMV in prematures. These
MAP and pressure amplitude lead to hypercapnia and,          studies present highly variable results. Since the onset
to maintain adequate elimination of carbon dioxide           it was well established that, just as in adults and in
(CO2), frequency may be reduced. However, hyper-             older children, MAP applied during HFOV had a di-
capnia must be accepted, because adjustment of the           rect correlation with oxygenation, therefore the high
respiratory rate to normalize CO 2 increases tidal vol-      values of MAP permitted ventilation with low FiO 2(19)
ume, with a worse air leak.(1,14)                            and no major hemodynamic aftermaths were observed.
                                                             It was noted that in prematures a given MAP needed
    Obstructive pulmonary disease                            to achieve and sustain alveolar expansions, could be
    Use of HFOV when facing increased resistance of          maintained. The oscillatory drives reopened atelactat-
the airways is controversial.(1,12) For some years HFOV      ic areas more efficiently than the same mean pressure
was contraindicated for obstructive pulmonary disease        maintained in an static way and that small volumes,
because of high risk of air trapping and dynamic hy-         generated a at a respiratory rate of 10 a 15 Hz, pro-
perinsuflation.(1,16) However, successful use of HFOV        vided a good safety margin to avoid overdistension of
in children with asthma and brochiolitis has been re-        the lung normal areas. (20)
ported. (15) This is probably due to the unique charac-          It must be recalled that benefits of HFOV in pre-
teristic of this ventilation mode, active expiration. In     matures became evident after establishing a ventilation
this condition, air is actively removed from the lungs       strategy based on recovery of the pulmonary volume
without risk of trapping. (16) Thus, in the previously       aiming at early reversion of the atelactatic areas by a
described condition, HFOV may be considered as an            more aggressive use of MAP and achieving a decrease
alternative when facing refractory respiratory acidosis      of FiO2 prior to decrease of pressures.(21)
caused by inadequate alveolar ventilation.                       A second fundamentally important aspect observed
    	    In one of the largest studies carried out in a      in studies comparing efficacy and safety of HFOV in
single center, including 53 patients of which 17 pre-        relation to CMV in neonatology, is the strategy used
sented withy obstructive disease, the open airway (17)       in CMV, where PEEP used often is relatively low, per-
technique was applied by carefully titrating MAP in          mitting alveolar collapse at the end of expiration, al-
HFOV to open airways and adjust ventilation,(18) a           though MAP remains at somewhat lower levels than
success for this therapy.                                    those of HFOV. This because the latter modality has
    In summary, in situations of obstructive pulmo-          the intrinsic advantage of keeping the lung at pres-
nary disease, it is always prudent to evaluate the risk      sures above the zone of alveolar collapse, in view of
and benefit of introducing HFOV.                             the small amplitude of tidal volume utilized. This fa-
                                                             cilitates maintenance of the lung at pressures above
   CLINICAL APPLICATIONS OF HFOV IN                          the lower inflection point of the pressure-volume
NEONATOLOGY                                                  curve, which is almost impossible in CMV. On the
   	                                                         contrary, especially in earlier studies, there was no
   Since introduction of HFOV in neonatology dur-            concern about using lower tidal volume values associ-
ing the sixties, a dramatic decrease of mortality (3) as     ated to adequate levels of PEEP.(21)
well as establishment of a new category of disease, ven-         After almost twenty studies comparing HFOV to
CMV in neonatology, it was shown that both treat-                      lomalacia: RR1.10; 95% CI 0.85-1.43).
ments are comparable in relation to mortality. Ini-                        Conversely to use of HFOV as a first form of treat-
tially, some studies suggested that HFOV was asso-                     ment in ARDS, use as a rescue therapy was reported in
ciated to a higher incidence of peri-intraventricular                  only two controlled studies, (27,28) without evidence of
hemorrhage, (22,23) resulting in some resistance to in-                improved evolution in the long term of newborn, be
troduction of HFOV as routine in extreme prema-                        it in chronic pulmonary disease, occurrence of neuro-
tures. However, in the last five years, strong evidence                logical complications, or survival.
has appeared that HFOV and CMV are equivalent                              Finally, HFOV has only shown a better result than
with regard to risk of evolving into intracranial hem-                 CMV during the neonatal period in relation to man-
orrhage in prematures. (24,25)                                         agement of extrapulmonary air. The few studies com-
     Safety and efficacy of HFOV were reviewed in                      paring HFOV to CMV in this situation demonstrate
2007 in a meta-analysis with 3585 children in 15 stud-                 that air leak through the thoracic drain is lower with
ies that compared this ventilation mode with CMV.(26)                  use of HFOV,(29,30) a fact confirmed in a case report(31)
The authors concluded that there is no evidence that                   and in an experimental study(32) which disclosed ben-
HFOV used as initial strategy presented advantages                     efit using HFOV in presence of a tracheoesophageal
in relation to CMV, regarding efficacy of ventilation                  or bronchopleural fistula.
or mortality at 28-30 days of age or age equivalent to                     To summarize, data currently available in literature
term. Nevertheless, authors found a small decrease in                  confirm that HFOV is a safe ventilation mode for use
the incidence of chronic pulmonary disease with 36-37                  in neonatology, however there is no evidence proving
weeks gestational age, corrected among survivors with                  a clear benefit or advantage of HFOV in relation to
use of HFOV. However, this evidence is weakened by                     CMV in newborn, be as initial or as rescue therapy.
inconsistency of results over the 15 studies and the                   The only clinical situation where there is evidence of
threshold significance (RR 0.89;95% CI:0.81-0.99).                     better results with HFOV is extrapulmonary air, espe-
Analyses of subgroups showed that there was a de-                      cially in bronchopleural fistula.
crease of chronic pulmonary disease when HFOV was
carried out with a high tidal volume strategy, when                      TRANSITION FROM CONVENTIONAL
piston oscillators were used to perform HFOV, when                     VENTILATION TO HIGH FREQUENCY VEN-
randomization took place between two to six hours of                   TILATION
life and when an inspiration/expiration ratio of 1:2
was used for HFOV. Some of the inconsistency of                            A patient transferred to HFOV must be duly mon-
these results is due to variability of the strategies used             itored regarding pulse oxymetry, relation PaO2/FiO2
for HFOV (high volume our reduced volume) as well                      and capnography. From the cardiovascular point of
as for CMV, over time.                                                 view, an adequate intravascular volume must be as-
    It is noteworthy that currently when the prenatal                  sured based upon peripheral perfusion, capillary fill-
use of corticoids to induce pulmonary maturity in the                  ing, arterial pressure and heart rate. The endotracheal
premature, exogenous surfactant and use of more pro-                   tube must be correctly positioned and preferably there
tective CMV techniques has become a routine, any                       should be a closed suction system of the tracheal tube.
benefit from HFOV in relation to CMV, probably will                    Sedation should be optimized and in some cases cura-
only be proven in new-born with severe pulmonary                       rization may be needed.
disease. For instance, Courtney et al. (24) showed that                    As already mentioned, early use of HFOV (24,33,34)
benefit of using HFOV in relation to CMV was only                      has received considerable attention. As such, for chil-
observed when inclusion was restricted to new-born                     dren after the neonatal period and with ARDS, when
of very low weight that met criteria of major sever-                   SaO 2 is below 90%, in FiO 2 higher than 0.6, with
ity, based upon FiO 2 and MAP after administration                     inspiratory pressure (PIp) of 30-32 cmH2 and PEEP
of surfactant.                                                         higher than 10-12 cmH 2O, transfer from convention-
    Although the meta-analysis (26) disclosed increased                al to HFOV is recommended.
incidence of intreaventricular hemorrhage and of
leukoencephalomalacia with HFOV, in some studies                          Implementation of HFOV
these were not significant (intraventricular hemor-                       Initial parameters used in HFOV are: (1,2)
rhage: RR1.05; 95% C.I. 0.96-1.15 – leukoencepha-                         - sufficient FiO 2 to maintain SaO 2 ≥ 90% (100%
during the transition time from CMV to HFOV;                    The ability to achieve adequate oxygenation in
    - inspiratory time, 33% of the oscillatory cycle;       non-toxic FiO2 is the main indicator that MAP is ad-
    - frequency of 10 Hz for sucklings and from 5 to        equate. In general, chest radiography must be made to
8 Hz for older children or according to the patient’s       evaluate the level of pulmonary expansion and pres-
weight < 10kg = 10-12Hz; 11-20kg = 8-10Hz; 21-              ence of nine or more intercostal spaces is an indica-
40kg = 6-10Hz; > 40kg = 5-8Hz. For a term newborn           tor of superdistension. MAP may be reduced when
= 12 or 15 Hz and for newborn prematures/ very low          alveolar recruitment is considered satisfactory and a
weight =15 Hz;                                              lower transpulmoinary pressure is required to main-
    - flow must remain between 15 and 20 L/min,             tain the lung open. Verification of the level of pulmo-
depending upon the patient’s size and on the MAP            nary recruitment includes evaluation of gas exchange
required. In newborn use flow between 8 and 15 L/           efficiency (rate of oxygenation) need for oxygen and
min;                                                        chest X-ray exam. (1,2)
    - MAP form 2 to 4 cmH2O above that used for                 In summary, MAP may be increased from 1 to 2
CMV. MAP can later be increased to achieve SaO 2 ≥          cmH2O until FiO2 < 0.6 with SaO2 between 88-92%
90% with FiO 2 ≤ 0.6. For newborn with diffuse al-          in cases of ARDS. In cases of air leak syndrome, use of
veolar disease or air leak syndrome use MAP 3-5 cm-         a higher FiO2 (between 80% and 100%) is permitted,
H2O above CMV. An early rescue intervention may             especially in the first 12-24 hours to minimize MAP,
be made in newborn using MAP of 10-14 cmH2O.                while an adequate SaO 2 is achieved.
In newborn as well as in older children, if SaO2 falls
quickly below 90%, recruit manual ventilation and               Elimination of carbon dioxide
gradually increase MAP;                                         Ventilation adjustments are achieved by increasing
    - pressure amplitude (ΔP) will be that sufficient       pressure amplitude or by reducing frequency, although
to achieve perceptible movement of the thoracic wall        elimination of CO2 is more related to amplitude and less
(movement of the thigh root which is easily seen) that      with frequency. Change of inspiratory time and flow
may be modified to the desired ventilation levels by        increase are other maneuvers that may improve ventila-
evaluating PaCO 2. Changes in frequency also define         tion. Amplitude may be changed by a button that con-
alteration in PaCO2 and, to the contrary of what takes      trols movement of the electromagnetic piston. Increase
place in CMV, in HFOV there is fall of PaCO 2 when          of amplitude results in increase of tidal volume. Con-
FR is diminished. In newborn at term the ΔP can be          versely, decrease of amplitude supplies lower tidal vol-
≥ 25 cmH2O ands in prematures/ very low weight can          ume e reduces the ventilation minute. Increases of ∆P
be ≥ 16 cmH 2O.                                             from 2–5 cmH2O changes PaCO2 by 3–5 mmHg and
                                                            increase of ∆P of more than 5 cmH2O changes PaCO2
      VENTILATION HANDLING                                  by 5–10 mmHg. It is appropriate to reduce respiratory
                                                            rate only if carbon dioxide arterial pressure (PaCO2) is
    Oxygenation                                             refractory to changes of the ∆P.(1,2)
    Criteria to transfer a patient from CMV to HFOV             Choice of adequate amplitude is essentially re-
vary according to the team’s experience. In general,        sultant from visual clinical inspection of the level of
transference is based upon clinical judgment, index         movement of the patient’s thoracic wall and measure-
of oxygenation pressure peak that has been needed in        ment of blood gases. One characteristic of HFOV is
CMV and disease progression.(1,2)                           that intensity of the piston movement is inversely re-
    Because there is a strict relation between pulmo-       lated to frequency, that is to say increased frequency
nary volume and surface area of gas exchange, practi-       diminishes movement of the piston with an effective
cally all oxygenation in HFOV depends on MAP and            decrease of pressure amplitude and of released tidal
FiO2. When MAP is increased the pulmonary volumes           volume. Increase of the inspiratory time leads to in-
are recruited and oxygenation improves up to the op-        crease of tidal volume and may improve elimination
timal point, beyond which the lungs become hyper            of CO2 e oxygenation.(1)
expanded. If there is superdistension, alveolar capillar-       Flow is the determinant of MAP and interferes with
ies are compressed, thereby reducing the gas exchange       removal of CO2. Typically, the flow needed to achieve
area and of the PaO 2. Furthermore, a more significant      adequate mean airway pressure and maintain adequate
hemodynamic impairment may take place.(1)                   minute ventilation ranges from 20 to 40 L/min.